20+ years in Africa
IAVI’s Africa hub brings together a diverse team with deep expertise in scientific research, operations, and stakeholder engagement. In collaboration with clinical research center partners across Africa, we focus on locally relevant research toward the development of vaccines and biomedical interventions for HIV, tuberculosis, neglected and emerging infectious diseases, snakebite, and antimicrobial resistance. Our core teams and offices are in Kenya, Uganda, and South Africa.
- Community engagement is central to developing an effective HIV vaccine. In an era where science is evolving fast, we must involve communities to ensure that public health solutions are not only acceptable, but also affordable and accessible to the end users who are the communities themselves.Jauhara Nanyondo Associate Director, Community engagement
- An HIV vaccine is achievable especially when developed together with the people it seeks to benefit most. To do so, it is critical that we adopt a participant-centered approach in the design of clinical trials that taps into the resourcefulness, resilience, and knowledge of the participants and their communities.Yvonne Wangũi Machira Director, Socio-behavioral research
- As we embark on the third cohort of our Leadership Development Program, we remain steadfast in our commitment to develop a core group of scientific leaders who will be the driving force behind the next-generation AIDS vaccine. Capacity strengthening programs like the LDP are essential in empowering our network of scientists in Africa and India.Benard Kulohoma Director, Organization Capacity Development
1 of 3